Preclinical study of formulated recombinant nucleocapsid protein, the receptor binding domain of the spike protein, and truncated spike (S1) protein as vaccine candidates against COVID-19 in animal models.
Nazarian S, Olad G, Abdolhamidi R, Motamedi MJ, Kazemi R, Kordbacheh E, Felagari A, Olad H, Ahmadi A, Bahiraee A, Farahani P, Haghighi L, Hassani F, Hajhassan V, Nadi M, Sheikhi A, Salimian J, Amani J.
Nazarian S, et al. Among authors: ahmadi a.
Mol Immunol. 2022 Sep;149:107-118. doi: 10.1016/j.molimm.2022.06.007. Epub 2022 Jun 23.
Mol Immunol. 2022.
PMID: 35802999
Free PMC article.